Moreover, with use of prototype assays for three TAAs, p53, c-myc, and MUC1, 6/9 (67%) women were reported to show AAbs between 7 and 27 months before the cancer was diagnosed on the screening mammograms. This evidence concerns the gene TP53 and cancer.